1POYNARD T,McHUTCHISON J,MANNS M,et al.Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C[J].Gastroenterology,2002,122:1303-1313.
2GEORGE SL,BACON BR,BRUNT EM,et al.Clinical,virologic,histologic,and biochemical outcomets after successful HCV therapy:a 5-year follw-up of 150 patients[J].Hepatology,2009,49:729-738.
3HAMMEL P,COUVELARD A,O'TOOL D,et al.Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct[J].N Engl J Med,2001,344:418-423.
4YANG YF,ZHAO W,ZHONG YD,et al.Interferon therapy in chrnoic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma:a metaanalysis[J].J Viral Hepat,2009,16:265-271.
5FRIEDMAN SL,ROCKEY DC,BISSELL DM.Hepatic fibrsos 2006:report of the Third AASLD Single Topic Conference[J].Hepatology,2007,45:242-249.
6GINES P,WONG F,WATSON H,et al.Effects of satavaptan,a selective vasopressin V(2) receptor antagonist,on ascites and serum sodium in cirrhosis with hyponatremia:a randomized trial[J].Hepatology,2008,48:204-213.
8GINES P,URIZ J,CALAHORRA B,et al.Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis[J].Gastroenterology,2002,123:1839-1847.
9MOREAU R,ASSELAH T,CONDAT B,et al.Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis:a randomised pilot study[J].Gut,2002,50:90-94.
10SINGH V,DHEERENDRA PC,SINGH B,et al.Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics:a randomized pilot study[J].Am J Gastroenterol,2008,103:1399-1405.
5Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
